These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 20924409)

  • 41. Penetrance Estimates Over Time to First and Second Primary Cancer Diagnosis in Families with Li-Fraumeni Syndrome: A Single Institution Perspective.
    Shin SJ; Dodd-Eaton EB; Gao F; Bojadzieva J; Chen J; Kong X; Amos CI; Ning J; Strong LC; Wang W
    Cancer Res; 2020 Jan; 80(2):347-353. PubMed ID: 31719099
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Genetic counselling and high-penetrance susceptibility gene analysis reveal the novel CDKN2A p.D84V (c.251A>T) mutation in melanoma-prone families from Italy.
    Borroni RG; Manganoni AM; Grassi S; Grasso M; Diegoli M; Giorgianni C; Favalli V; Pavoni L; Cespa M; Arbustini E
    Melanoma Res; 2017 Apr; 27(2):97-103. PubMed ID: 28060055
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estimating the efficacy and efficiency of cascade genetic screening.
    Krawczak M; Cooper DN; Schmidtke J
    Am J Hum Genet; 2001 Aug; 69(2):361-70. PubMed ID: 11431707
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group.
    Anglian Breast Cancer Study Group
    Br J Cancer; 2000 Nov; 83(10):1301-8. PubMed ID: 11044354
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families.
    Pharoah PD; Guilford P; Caldas C;
    Gastroenterology; 2001 Dec; 121(6):1348-53. PubMed ID: 11729114
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Attenuation of disease phenotype through alternative translation initiation in low-penetrance retinoblastoma.
    Sánchez-Sánchez F; Ramírez-Castillejo C; Weekes DB; Beneyto M; Prieto F; Nájera C; Mittnacht S
    Hum Mutat; 2007 Feb; 28(2):159-67. PubMed ID: 16988938
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Penetrance and clinical features of pheochromocytoma in a six-generation family carrying a germline TMEM127 mutation.
    Toledo SP; Lourenço DM; Sekiya T; Lucon AM; Baena ME; Castro CC; Bortolotto LA; Zerbini MC; Siqueira SA; Toledo RA; Dahia PL
    J Clin Endocrinol Metab; 2015 Feb; 100(2):E308-18. PubMed ID: 25389632
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Penetrance of a rare familial mutation predisposing to papillary thyroid cancer.
    Saporito D; Brock P; Hampel H; Sipos J; Fernandez S; Liyanarachchi S; de la Chapelle A; Nagy R
    Fam Cancer; 2018 Jul; 17(3):431-434. PubMed ID: 29027612
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations.
    Box NF; Duffy DL; Chen W; Stark M; Martin NG; Sturm RA; Hayward NK
    Am J Hum Genet; 2001 Oct; 69(4):765-73. PubMed ID: 11500805
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.
    Begg CB; Orlow I; Hummer AJ; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Gruber SB; Anton-Culver H; Zanetti R; Gallagher RP; Dwyer T; Rebbeck TR; Mitra N; Busam K; From L; Berwick M;
    J Natl Cancer Inst; 2005 Oct; 97(20):1507-15. PubMed ID: 16234564
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study.
    Antoniou AC; Pharoah PD; McMullan G; Day NE; Ponder BA; Easton D
    Genet Epidemiol; 2001 Jul; 21(1):1-18. PubMed ID: 11443730
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers.
    Rijken JA; Niemeijer ND; Jonker MA; Eijkelenkamp K; Jansen JC; van Berkel A; Timmers HJLM; Kunst HPM; Bisschop PHLT; Kerstens MN; Dreijerink KMA; van Dooren MF; van der Horst-Schrivers ANA; Hes FJ; Leemans CR; Corssmit EPM; Hensen EF
    Clin Genet; 2018 Jan; 93(1):60-66. PubMed ID: 28503760
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Various penetrance of familial medullary thyroid carcinoma in patients with RET protooncogene codon 790/791 germline mutations.
    Fitze G; Schierz M; Bredow J; Saeger HD; Roesner D; Schackert HK
    Ann Surg; 2002 Nov; 236(5):570-5. PubMed ID: 12409662
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Statistical inference on the penetrances of rare genetic mutations based on a case-family design.
    Zhang H; Olschwang S; Yu K
    Biostatistics; 2010 Jul; 11(3):519-32. PubMed ID: 20179148
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Detection of disease genes by use of family data. I. Likelihood-based theory.
    Whittemore AS; Tu IP
    Am J Hum Genet; 2000 Apr; 66(4):1328-40. PubMed ID: 10739758
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estimating the odds ratios of Crohn disease for the main CARD15/NOD2 mutations using a conditional maximum likelihood method in pedigrees collected via affected family members.
    Pascoe L; Zouali H; Sahbatou M; Hugot JP
    Eur J Hum Genet; 2007 Aug; 15(8):864-71. PubMed ID: 17457368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of parent-of-origin effects using general pedigree data.
    Zhou JY; Ding J; Fung WK; Lin S
    Genet Epidemiol; 2010 Feb; 34(2):151-8. PubMed ID: 19676055
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of familial melanoma.
    Bishop JN; Harland M; Randerson-Moor J; Bishop DT
    Lancet Oncol; 2007 Jan; 8(1):46-54. PubMed ID: 17196510
    [TBL] [Abstract][Full Text] [Related]  

  • 59. von Hippel-Lindau disease: Diagnosis and factors influencing disease outcome.
    Binderup MLM
    Dan Med J; 2018 Mar; 65(3):. PubMed ID: 29510814
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hereditary breast cancer; Genetic penetrance and current status with BRCA.
    Mahdavi M; Nassiri M; Kooshyar MM; Vakili-Azghandi M; Avan A; Sandry R; Pillai S; Lam AK; Gopalan V
    J Cell Physiol; 2019 May; 234(5):5741-5750. PubMed ID: 30552672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.